Literature DB >> 21131631

Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study.

Aravind Sugumar1, Michael J Levy, Terumi Kamisawa, G J Webster, George J M Webster, Myung-Hwan Kim, Felicity Enders, Zahir Amin, Todd H Baron, Mike H Chapman, Nicholas I Church, Jonathan E Clain, Naoto Egawa, Gavin J Johnson, Kazuichi Okazaki, Randall K Pearson, Stephen P Pereira, Bret T Petersen, Samantha Read, Raghuwansh P Sah, Neomal S Sandanayake, Naoki Takahashi, Mark D Topazian, Kazushige Uchida, Santhi Swaroop Vege, Suresh T Chari.   

Abstract

BACKGROUND: Characteristic pancreatic duct changes on endoscopic retrograde pancreatography (ERP) have been described in autoimmune pancreatitis (AIP). The performance characteristics of ERP to diagnose AIP were determined.
METHODS: The study was done in two phases. In phase I, 21 physicians from four centres in Asia, Europe and the USA, unaware of the clinical data or diagnoses, reviewed 40 preselected ERPs of patients with AIP (n=20), chronic pancreatitis (n=10) and pancreatic cancer (n=10). Physicians noted the presence or absence of key pancreatographic features and ranked the diagnostic possibilities. For phase II, a teaching module was created based on features found most useful in the diagnosis of AIP by the four best performing physicians in phase I. After a washout period of 3 months, all physicians reviewed the teaching module and reanalysed the same set of ERPs, unaware of their performance in phase I.
RESULTS: In phase I the sensitivity, specificity and interobserver agreement of ERP alone to diagnose AIP were 44, 92 and 0.23, respectively. The four key features of AIP identified in phase I were (i) long (>1/3 the length of the pancreatic duct) stricture; (ii) lack of upstream dilatation from the stricture (<5 mm); (iii) multiple strictures; and (iv) side branches arising from a strictured segment. In phase II the sensitivity (71%) of ERP significantly improved (p<0.05) without a significant decline in specificity (83%) (p>0.05); the interobserver agreement was fair (0.40).
CONCLUSIONS: The ability to diagnose AIP based on ERP features alone is limited but can be improved with knowledge of some key features.

Entities:  

Mesh:

Year:  2010        PMID: 21131631     DOI: 10.1136/gut.2010.207951

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  28 in total

Review 1.  Clinical and pathophysiological issues associated with type 1 autoimmune pancreatitis.

Authors:  Kazushige Uchida; Hideaki Miyoshi; Tsukasa Ikeura; Masaaki Shimatani; Makoto Takaoka; Kazuichi Okazaki
Journal:  Clin J Gastroenterol       Date:  2016-02-10

Review 2.  IgG4-related disease: a new kid on the block or an old aquaintance?

Authors:  Georg Beyer; Theresa Schwaiger; Markus M Lerch; Julia Mayerle
Journal:  United European Gastroenterol J       Date:  2014-06       Impact factor: 4.623

3.  Autoimmune Pancreatitis Masquerading as Pancreatic Cancer: when in Doubt, Cut It Out.

Authors:  Henry Y Jiang; Erica L Kohtakangas; Bojana Mitrovic; Kengo Asai; Jeffrey B Shum
Journal:  J Gastrointest Cancer       Date:  2018-09

4.  Autoimmune Pancreatitis: A Multiorgan Disease Presenting a Conundrum for Clinicians in the West.

Authors:  Eileen Kim; Rebecca Voaklander; Franklin E Kasmin; William H Brown; Rifat Mannan; Jerome H Siegel
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-09

Review 5.  IgG4-related autoimmune diseases: Polymorphous presentation complicates diagnosis and treatment.

Authors:  Alexander Kleger; Thomas Seufferlein; Martin Wagner; Andrea Tannapfel; Thomas K Hoffmann; Julia Mayerle
Journal:  Dtsch Arztebl Int       Date:  2015-02-20       Impact factor: 5.594

6.  Autoimmune Pancreatitis.

Authors:  Gyanprakash A Ketwaroo; Sunil Sheth
Journal:  Gastroenterol Rep       Date:  2013-04-04       Impact factor: 3.651

Review 7.  Endoscopic retrograde cholangiopancreatography and intraductal ultrasonography in the diagnosis of autoimmune pancreatitis and IgG4-related sclerosing cholangitis.

Authors:  Itaru Naitoh; Takahiro Nakazawa
Journal:  J Med Ultrason (2001)       Date:  2021-07-31       Impact factor: 1.314

8.  [Autoimmune pancreatitis--treatment and pitfalls in diagnostics].

Authors:  S Rasch; V Phillip; G Weirich; I Esposito; J Gaa; R M Schmid; H Algül
Journal:  Internist (Berl)       Date:  2014-10       Impact factor: 0.743

9.  Reduction of splenic volume by steroid therapy in cases with autoimmune pancreatitis.

Authors:  Hiroyuki Matsubayashi; Katsuhiko Uesaka; Hideyuki Kanemoto; Takeshi Aramaki; Yoshihiro Nakaya; Naomi Kakushima; Hiroyuki Ono
Journal:  J Gastroenterol       Date:  2012-10-18       Impact factor: 7.527

Review 10.  Endoscopic retrograde pancreatography: When should we do it?

Authors:  Renáta Bor; László Madácsy; Anna Fábián; Attila Szepes; Zoltán Szepes
Journal:  World J Gastrointest Endosc       Date:  2015-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.